The Site and Monitoring Health Lead (SMH Lead) applies regulatory and GCP knowledge and monitoring experience to safeguard the quality of clinical trial execution at investigator sites and oversee CRO monitoring effectiveness. This is a site-facing role that reports to the Associate Director, Site and Monitoring Health or above. Travel is required, generally expected to be less than 50%, with occasional increases based on business needs; local, regional, and international travel may be required. The SMH Lead implements Alnylam’s Site and Monitoring Health strategy in alignment with ICH GCP E6 and E8, applies risk-based thinking, and maintains inspection readiness. The role develops or follows Study Specific Oversight Plans (SSOPs), conducts and documents oversight activities, builds relationships with investigators and site staff, assesses site and study risks, and partners with study teams, CROs, and Clinical Risk & Analytics staff to address issues and trends. The role also supports less experienced research sites, inspection preparation and management, and administrative activities. Alnylam describes itself as a leader in RNAi therapeutics and highlights its values of fierce innovation, passion for excellence, purposeful urgency, open culture, and commitment to people. The role is eligible for annual short- and long-term incentive awards. The stated U.S. base salary range is $123,300–$166,800. Alnylam offers medical, dental, and vision coverage; life and disability insurance; a lifestyle reimbursement program; flexible spending and health savings accounts; a 401(k) with company match; paid time off, wellness days, holidays, and company-wide recharge breaks; and family resources and leave.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Manager